Suppr超能文献

种族和族裔对美国老年医疗保险受益人群流感疫苗接种率的影响:一项记录链接队列研究。

Effect of race and ethnicity on influenza vaccine uptake among older US Medicare beneficiaries: a record-linkage cohort study.

作者信息

Mahmud Salaheddin M, Xu Liou, Hall Laura Lee, Puckrein Gary, Thommes Edward, Loiacono Matthew M, Chit Ayman

机构信息

Vaccine and Drug Evaluation Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

National Minority Quality Forum, Washington, DC, USA.

出版信息

Lancet Healthy Longev. 2021 Mar;2(3):e143-e153. doi: 10.1016/S2666-7568(20)30074-X. Epub 2021 Feb 18.

Abstract

BACKGROUND

Seasonal influenza vaccine (SIV) uptake among US adults aged 65 years or older remains suboptimal and stagnant. Further, there is growing concern around racial and ethnic disparities in uptake. We aimed to assess racial and ethnic disparities in overall SIV and in high-dose vaccine (HDV) uptake among Medicare beneficiaries during the 2015-16 influenza season and sought to identify possible mediators for observed disparities.

METHODS

We did a historical record-linkage cohort study using Medicare (a US national health insurance programme) databases, which included all older adults (≥65 years) enrolled in Medicare during the study period (July 1, 2015, to June 30, 2016). We excluded beneficiaries of Medicare Part C (managed care offered by private companies), and residents of long-term care facilities. The primary outcome was SIV receipt during the study period, classified into receipt of HDV and standard-dose vaccines (SDVs, representing all other SIVs). SIV uptake probabilities were estimated using competing-risk survival analysis methods. Mediation analyses were done to investigate potential mediators of the association between race and ethnicity and uptake.

FINDINGS

During the study period, of 26·5 million beneficiaries in the study cohort, 47·4% received a SIV, 52·7% of whom received HDV. Compared with white beneficiaries (49·4%), Hispanic (29·1%), Black (32·6%), and Asian (47·6%) beneficiaries were less likely to be vaccinated and, when vaccinated, were less likely to receive HDV (37·8% for Hispanic people, 41·1% for Black people, and 40·3% for Asian people, compared with 53·8% of white people who received HDV). Among those vaccinated, after accounting for region, income, chronic conditions, and health-care use, minority groups were 26-32% less likely to receive HDV, relative to white people (odds ratio [OR] 0·68 [95% CI 0·68-0·69] for Black people; OR 0·71 [0·71-0·72] for Asian people; and OR 0·74 [0·73-0·74] for Hispanic people).

INTERPRETATION

Substantial racial and ethnic disparities in SIV uptake among Medicare beneficiaries aged 65 years or older are evident. New legislative, fiscal, and educational strategies are urgently needed to address these inequities.

FUNDING

Sanofi Pasteur.

摘要

背景

65岁及以上美国成年人的季节性流感疫苗(SIV)接种率仍不理想且停滞不前。此外,人们越来越关注接种率方面的种族和族裔差异。我们旨在评估2015 - 16流感季节医疗保险受益人群中SIV总体接种情况以及高剂量疫苗(HDV)接种情况的种族和族裔差异,并试图找出导致观察到的差异的可能中介因素。

方法

我们使用医疗保险(一项美国国家医疗保险计划)数据库进行了一项历史记录链接队列研究,该数据库包括研究期间(2015年7月1日至2016年6月30日)登记参加医疗保险的所有老年人(≥65岁)。我们排除了医疗保险C部分(由私人公司提供的管理式医疗)的受益人和长期护理机构的居民。主要结局是研究期间的SIV接种情况,分为HDV接种和标准剂量疫苗(SDV,代表所有其他SIV)接种。使用竞争风险生存分析方法估计SIV接种概率。进行中介分析以调查种族和族裔与接种之间关联的潜在中介因素。

结果

在研究期间,研究队列中的2650万受益人中,47.4%接种了SIV,其中52.7%接种了HDV。与白人受益人(49.4%)相比,西班牙裔(29.1%)、黑人(32.6%)和亚裔(47.6%)受益人接种疫苗的可能性较小,并且在接种疫苗时,接受HDV的可能性也较小(西班牙裔为37.8%,黑人为41.1%,亚裔为40.3%,而接受HDV的白人比例为53.8%)。在接种疫苗的人群中,在考虑了地区、收入、慢性病和医疗保健使用情况后,少数群体接受HDV的可能性比白人低26% - 32%(黑人的比值比[OR]为0.68[95%CI 0.68 - 0.69];亚裔为OR 0.71[0.71 - 0.72];西班牙裔为OR 0.74[0.73 - 0.74])。

解读

65岁及以上医疗保险受益人群在SIV接种方面存在明显的种族和族裔差异。迫切需要新的立法、财政和教育策略来解决这些不平等问题。

资助

赛诺菲巴斯德公司。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验